TELEFLEX INC (TFX) Fundamental Analysis & Valuation

NYSE:TFX • US8793691069

111.75 USD
-0.09 (-0.08%)
At close: Mar 11, 2026
111.75 USD
0 (0%)
After Hours: 3/11/2026, 4:15:00 PM

This TFX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall TFX gets a fundamental rating of 4 out of 10. We evaluated TFX against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of TFX get a neutral evaluation. Nothing too spectacular is happening here. TFX is cheap, but on the other hand it scores bad on growth. With these ratings, TFX could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

5

1. TFX Profitability Analysis

1.1 Basic Checks

  • In the past year TFX was profitable.
  • In the past year TFX had a positive cash flow from operations.
  • TFX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years TFX had a positive operating cash flow.
TFX Yearly Net Income VS EBIT VS OCF VS FCFTFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • TFX has a Return On Assets of -13.04%. This is comparable to the rest of the industry: TFX outperforms 57.07% of its industry peers.
  • The Return On Equity of TFX (-28.98%) is comparable to the rest of the industry.
  • TFX's Return On Invested Capital of 5.83% is fine compared to the rest of the industry. TFX outperforms 78.26% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TFX is significantly below the industry average of 9.15%.
  • The last Return On Invested Capital (5.83%) for TFX is above the 3 year average (3.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -13.04%
ROE -28.98%
ROIC 5.83%
ROA(3y)-2.44%
ROA(5y)1%
ROE(3y)-6.44%
ROE(5y)0.53%
ROIC(3y)3.28%
ROIC(5y)4.67%
TFX Yearly ROA, ROE, ROICTFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • TFX has a better Operating Margin (15.41%) than 83.15% of its industry peers.
  • In the last couple of years the Operating Margin of TFX has declined.
  • TFX has a Gross Margin (53.30%) which is in line with its industry peers.
  • TFX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.41%
PM (TTM) N/A
GM 53.3%
OM growth 3Y-11.31%
OM growth 5Y-8.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y1.5%
TFX Yearly Profit, Operating, Gross MarginsTFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

5

2. TFX Health Analysis

2.1 Basic Checks

  • TFX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • TFX has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TFX has been reduced compared to 5 years ago.
  • TFX has a worse debt/assets ratio than last year.
TFX Yearly Shares OutstandingTFX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
TFX Yearly Total Debt VS Total AssetsTFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • TFX has an Altman-Z score of 2.26. This is not the best score and indicates that TFX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of TFX (2.26) is better than 64.67% of its industry peers.
  • TFX has a debt to FCF ratio of 10.76. This is a negative value and a sign of low solvency as TFX would need 10.76 years to pay back of all of its debts.
  • TFX's Debt to FCF ratio of 10.76 is fine compared to the rest of the industry. TFX outperforms 72.83% of its industry peers.
  • TFX has a Debt/Equity ratio of 0.81. This is a neutral value indicating TFX is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.81, TFX is not doing good in the industry: 71.74% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 10.76
Altman-Z 2.26
ROIC/WACC0.61
WACC9.6%
TFX Yearly LT Debt VS Equity VS FCFTFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.54 indicates that TFX has no problem at all paying its short term obligations.
  • TFX has a Current ratio (2.54) which is comparable to the rest of the industry.
  • A Quick Ratio of 2.01 indicates that TFX has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.01, TFX perfoms like the industry average, outperforming 51.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.01
TFX Yearly Current Assets VS Current LiabilitesTFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1

3. TFX Growth Analysis

3.1 Past

  • TFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.63%.
  • The Earnings Per Share has been growing slightly by 2.78% on average over the past years.
  • TFX shows a decrease in Revenue. In the last year, the revenue decreased by -2.75%.
  • TFX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.72% yearly.
EPS 1Y (TTM)-12.63%
EPS 3Y-2.14%
EPS 5Y2.78%
EPS Q2Q%-50.39%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y-10.62%
Revenue growth 5Y-4.72%
Sales Q2Q%-28.47%

3.2 Future

  • TFX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.79% yearly.
  • TFX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.02% yearly.
EPS Next Y-6.4%
EPS Next 2Y0.56%
EPS Next 3Y-4.92%
EPS Next 5Y-1.79%
Revenue Next Year-12.37%
Revenue Next 2Y-4.6%
Revenue Next 3Y-8.6%
Revenue Next 5Y-3.02%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TFX Yearly Revenue VS EstimatesTFX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
TFX Yearly EPS VS EstimatesTFX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

7

4. TFX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.13, which indicates a very decent valuation of TFX.
  • Based on the Price/Earnings ratio, TFX is valued cheaply inside the industry as 92.93% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.25. TFX is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 9.75, which indicates a very decent valuation of TFX.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TFX indicates a rather cheap valuation: TFX is cheaper than 95.11% of the companies listed in the same industry.
  • TFX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.39.
Industry RankSector Rank
PE 9.13
Fwd PE 9.75
TFX Price Earnings VS Forward Price EarningsTFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.04% of the companies in the same industry are more expensive than TFX, based on the Enterprise Value to EBITDA ratio.
  • 89.67% of the companies in the same industry are more expensive than TFX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.12
EV/EBITDA 11.36
TFX Per share dataTFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • TFX's earnings are expected to decrease with -4.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)3.28
EPS Next 2Y0.56%
EPS Next 3Y-4.92%

4

5. TFX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.16%, TFX has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.21, TFX pays a better dividend. On top of this TFX pays more dividend than 94.57% of the companies listed in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.82, TFX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

  • The dividend of TFX decreases each year by -0.38%.
  • TFX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As TFX did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.38%
Div Incr Years0
Div Non Decr Years6
TFX Yearly Dividends per shareTFX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • TFX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • TFX's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-6.65%
EPS Next 2Y0.56%
EPS Next 3Y-4.92%
TFX Yearly Income VS Free CF VS DividendTFX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

TFX Fundamentals: All Metrics, Ratios and Statistics

TELEFLEX INC

NYSE:TFX (3/11/2026, 4:15:00 PM)

After market: 111.75 0 (0%)

111.75

-0.09 (-0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)04-29
Inst Owners107.99%
Inst Owner Change-1.36%
Ins Owners0.22%
Ins Owner Change14.43%
Market Cap4.94B
Revenue(TTM)2.96B
Net Income(TTM)-905.64M
Analysts65.56
Price Target137.93 (23.43%)
Short Float %5.56%
Short Ratio2.52
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly Dividend1.33
Dividend Growth(5Y)-0.38%
DP-6.65%
Div Incr Years0
Div Non Decr Years6
Ex-Date03-06
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.71%
Min EPS beat(2)-48.83%
Max EPS beat(2)7.42%
EPS beat(4)2
Avg EPS beat(4)-8.2%
Min EPS beat(4)-48.83%
Max EPS beat(4)9.84%
EPS beat(8)5
Avg EPS beat(8)-3.27%
EPS beat(12)9
Avg EPS beat(12)-0.42%
EPS beat(16)13
Avg EPS beat(16)0.27%
Revenue beat(2)1
Avg Revenue beat(2)-18.73%
Min Revenue beat(2)-38.72%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)-9.51%
Min Revenue beat(4)-38.72%
Max Revenue beat(4)1.26%
Revenue beat(8)3
Avg Revenue beat(8)-5.44%
Revenue beat(12)6
Avg Revenue beat(12)-3.31%
Revenue beat(16)7
Avg Revenue beat(16)-2.86%
PT rev (1m)0%
PT rev (3m)1.23%
EPS NQ rev (1m)-30.33%
EPS NQ rev (3m)-30.26%
EPS NY rev (1m)-20.93%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)-22.82%
Revenue NQ rev (3m)-23.29%
Revenue NY rev (1m)-20.71%
Revenue NY rev (3m)-20.97%
Valuation
Industry RankSector Rank
PE 9.13
Fwd PE 9.75
P/S 1.67
P/FCF 20.12
P/OCF 14.5
P/B 1.58
P/tB N/A
EV/EBITDA 11.36
EPS(TTM)12.24
EY10.95%
EPS(NY)11.46
Fwd EY10.25%
FCF(TTM)5.55
FCFY4.97%
OCF(TTM)7.71
OCFY6.9%
SpS67.05
BVpS70.7
TBVpS-15.94
PEG (NY)N/A
PEG (5Y)3.28
Graham Number139.53
Profitability
Industry RankSector Rank
ROA -13.04%
ROE -28.98%
ROCE 7.39%
ROIC 5.83%
ROICexc 6.21%
ROICexgc 18.25%
OM 15.41%
PM (TTM) N/A
GM 53.3%
FCFM 8.28%
ROA(3y)-2.44%
ROA(5y)1%
ROE(3y)-6.44%
ROE(5y)0.53%
ROIC(3y)3.28%
ROIC(5y)4.67%
ROICexc(3y)3.44%
ROICexc(5y)4.94%
ROICexgc(3y)14.94%
ROICexgc(5y)24.92%
ROCE(3y)4.15%
ROCE(5y)5.91%
ROICexgc growth 3Y-32.67%
ROICexgc growth 5Y-21.74%
ROICexc growth 3Y-19.62%
ROICexc growth 5Y-11.23%
OM growth 3Y-11.31%
OM growth 5Y-8.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y1.5%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 10.76
Debt/EBITDA 4.01
Cap/Depr 53.58%
Cap/Sales 3.21%
Interest Coverage 3.83
Cash Conversion 53.69%
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 2.01
Altman-Z 2.26
F-Score4
WACC9.6%
ROIC/WACC0.61
Cap/Depr(3y)46.97%
Cap/Depr(5y)41.09%
Cap/Sales(3y)4.27%
Cap/Sales(5y)3.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.63%
EPS 3Y-2.14%
EPS 5Y2.78%
EPS Q2Q%-50.39%
EPS Next Y-6.4%
EPS Next 2Y0.56%
EPS Next 3Y-4.92%
EPS Next 5Y-1.79%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y-10.62%
Revenue growth 5Y-4.72%
Sales Q2Q%-28.47%
Revenue Next Year-12.37%
Revenue Next 2Y-4.6%
Revenue Next 3Y-8.6%
Revenue Next 5Y-3.02%
EBIT growth 1Y-16.3%
EBIT growth 3Y-20.73%
EBIT growth 5Y-12.48%
EBIT Next Year-18.47%
EBIT Next 3Y-6.15%
EBIT Next 5Y7.42%
FCF growth 1Y-54.99%
FCF growth 3Y-2.27%
FCF growth 5Y-6.62%
OCF growth 1Y-46.41%
OCF growth 3Y-0.14%
OCF growth 5Y-4.83%

TELEFLEX INC / TFX FAQ

What is the ChartMill fundamental rating of TELEFLEX INC (TFX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TFX.


What is the valuation status for TFX stock?

ChartMill assigns a valuation rating of 7 / 10 to TELEFLEX INC (TFX). This can be considered as Undervalued.


What is the profitability of TFX stock?

TELEFLEX INC (TFX) has a profitability rating of 5 / 10.


What is the valuation of TELEFLEX INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TELEFLEX INC (TFX) is 9.13 and the Price/Book (PB) ratio is 1.58.


How financially healthy is TELEFLEX INC?

The financial health rating of TELEFLEX INC (TFX) is 5 / 10.